Strata Critical Medical, Inc.
NASDAQ:SRTAAirlines, Airports & Air Services
Industrials
$4.96 -0.43%
-$0.03 today
- Market cap
- $443.03M
- Beta
- 2.20
- P/E (TTM)
- 9.7
- EPS (TTM)
- $0.60
52W Low $3.57High $6.50
Volume 0.99M
Average 0.91M
Income Statement
Follow revenue through to earnings.
Revenue
$197.14M
FY 2025 · Annual
-20.7% YoYOperating Income
-$9.81M
FY 2025 · Annual
Net Income
-$15.65M
FY 2025 · Annual
Income Statement
USD
Metric | FY2021 Sep 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 50.53M | 146.12M | 225.18M | 248.69M | 197.14M |
| Cost of Revenue | 40.01M | 123.85M | 183.06M | 189.77M | 158.82M |
| Gross Profit | 10.52M | 22.28M | 42.12M | 58.92M | 38.33M |
| Gross Margin | 20.8% | 15.2% | 18.7% | 23.7% | 19.4% |
| Research & Development | 1.68M | 5.55M | 4.63M | 3.18M | 3.05M |
| Selling, General & Admin | 32.93M | 70.26M | 105.61M | 89.66M | 45.08M |
| Operating Expenses | 34.61M | 75.8M | 110.24M | 92.85M | 48.13M |
| Depreciation & Amortization | 596K | 5.73M | 7.11M | 5.96M | 6.9M |
| EBITDA | (43.1M) | (22.31M) | (50.43M) | (21.6M) | (13.17M) |
| EBITDA Margin | -85.3% | -15.3% | -22.4% | -8.7% | -6.7% |
| Operating Income | (24.09M) | (53.53M) | (68.12M) | (33.93M) | (9.81M) |
| Operating Margin | -47.7% | -36.6% | -30.3% | -13.6% | -5.0% |
| Interest Income | 460K | 3.43M | 8.44M | 7.21M | 4.24M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | (19.6M) | 25.5M | 10.58M | 6.36M | (10.26M) |
| Income Before Tax | (43.7M) | (28.03M) | (57.54M) | (27.56M) | (20.07M) |
| Pre-Tax Margin | -86.5% | -19.2% | -25.6% | -11.1% | -10.2% |
| Income Tax Expense | (3.64M) | (772K) | (1.47M) | (255K) | 0 |
| Net Income | (40.05M) | (27.26M) | (56.08M) | (27.31M) | (15.65M) |
| Net Margin | -79.3% | -18.7% | -24.9% | -11.0% | -7.9% |
| EPS (Basic) | (0.57) | (0.38) | (0.76) | (0.35) | (0.19) |
| EPS (Diluted) | (0.57) | (0.38) | (0.76) | (0.35) | (0.19) |
| 70.1M | 71.24M | 73.52M | 77.5M | 82.45M | |
| 70.1M | 71.24M | 73.52M | 77.5M | 82.45M |
SRTA Earnings Waterfall · TTM
NASDAQ:SRTA · Revenue to Net Income
Key Ratios
EPS$-0.16
Gross Margin20.7%
Net Margin26.7%
P/E Ratio-0.7
P/S Ratio6.1
Analysis
$254.3M of revenue converted into $50.8M of net income for the selected period. Gross margin is 20.7% and net margin is 26.7%, showing how much revenue survives after costs and taxes. EPS is $-0.16, tying the income statement back to per-share earnings.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Nov 9, 2026 | |
| 10-Q | Quarterly report | Nov 3, 2026 | |
| 8-K | Current report | Nov 3, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 30, 2026 | |
| SC 13D | SC 13D filing | Oct 15, 2026 |
How much revenue does SRTA generate?
Strata Critical Medical, Inc. (SRTA) reported $197.14M of revenue in fiscal 2025.
Is SRTA profitable?
Strata Critical Medical, Inc. (SRTA) reported -$15.65M of net income, with a net margin of -7.9%.
Continue the stock analysis
Jump to another research area for this company.